Methyl 4-aminobenzoate structure
|
Common Name | Methyl 4-aminobenzoate | ||
|---|---|---|---|---|
| CAS Number | 619-45-4 | Molecular Weight | 151.163 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 299.2±13.0 °C at 760 mmHg | |
| Molecular Formula | C8H9NO2 | Melting Point | 110-111 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 154.9±17.4 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | Methyl 4-aminobenzoate |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 299.2±13.0 °C at 760 mmHg |
| Melting Point | 110-111 °C(lit.) |
| Molecular Formula | C8H9NO2 |
| Molecular Weight | 151.163 |
| Flash Point | 154.9±17.4 °C |
| Exact Mass | 151.063324 |
| PSA | 52.32000 |
| LogP | 1.41 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.566 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R20/21/22;R36/37/38 |
| Safety Phrases | S26-S37/39-S36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | DG2900000 |
| HS Code | 2922499990 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2922499990 |
|---|---|
| Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
|
Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
J. Drug Target. 22(7) , 619-28, (2014) Nanoparticles are widely used as drug carriers for controlled, tumor-targeted delivery of various anticancer agents that have biopharmaceutical limitations such as water solubility and tissue permeabi... |
|
|
Application of stripping voltammetry to trace lead analysis in intermediates and final products of syntheses of pharmaceuticals.
J. Pharm. Biomed. Anal. 14(7) , 765-71, (1996) Applications of differential pulse anodic stripping voltammetry using a new pen-type renewed hanging mercury electrode have been investigated for trace analysis of lead in pharmaceutical substances an... |
|
|
In Silico Estimation of Skin Concentration Following the Dermal Exposure to Chemicals.
Pharm. Res. 32 , 3965-74, (2015) To develop an in silico method based on Fick's law of diffusion to estimate the skin concentration following dermal exposure to chemicals with a wide range of lipophilicity.Permeation experiments of v... |
| Benzoic acid, 4-amino-, methyl ester |
| 4-(Methoxycarbonyl)aniline |
| Methyl-4-aminobenzolcarboxylat |
| Benzoic acid,4-amino-,methyl ester |
| EINECS 210-598-7 |
| Methyl 4-aminobenzoate |
| 4-Aminobenzoic acid methyl ester |
| p-aminobenzoic acid methyl ester |
| Benzoic acid,p-amino-,methyl ester |
| p-(Methoxycarbonyl)aniline |
| METHYL P-AMINOBENZOATE |
| Methyl aniline-4-carboxylate |
| methyl 4-amino-benzoate |
| methyl ester of p-aminobenzoic acid |
| Methy-4-amino-benzoic acid |
| 4-Carbomethoxyaniline |
| MFCD00007891 |